Montelukast therapy and psychological distress in chronic obstructive pulmonary disease (COPD): A preliminary report

Archives of Gerontology and Geriatrics

Volumn 52, Issue 1, 2011, Pages

  Gueli, Nicolò ^a   Verrusio, Walter ^a   Linguanti, Adele ^a   De Santis, Wladimiro ^a   Canitano, Nicoletta ^a   Ippoliti, Flora ^a   Marigliano, Vincenzo ^a   Cacciafesta, Mauro ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chronic obstructive pulmonary disease (COPD); Cytokines; Montelukast therapy

Indexed keywords

INTERLEUKIN 12P70; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; MONTELUKAST; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONSULTATION; DISTRESS SYNDROME; FEMALE; HOSPITALIZATION; HUMAN; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGIC ASSESSMENT;

ACETATES; AGED; ANTI-ASTHMATIC AGENTS; FEMALE; HOSPITALIZATION; HUMANS; INTERLEUKIN-8; LEUKOTRIENE B4; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUINOLINES; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649713316     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2010.04.014     Document Type: Article

References (38)

1. Andenaes R., Kalfoss M.H. Psychological distress in hospitalized patients with chronic obstructive pulmonary disease. Eur. J. Epidemiol. 2004, 19:851-859.
2. Angerio A.D. Chronic obstructive pulmonary disease and cytokines. Crit. Care Nurs. Q. 2008, 31:321-323.
3. Barnes P.J. The cytokine network in asthma and chronic obstructive pulmonary disease. J. Clin. Invest. 2008, 118:3546-3556.
4. Bhowmik A., Seemungal T.A., Sapsford R.J., Wedzicha J.A. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000, 55:114-120.
5. Chang S.W. TNF potentiates PAF-induced pulmonary vasoconstriction in the rat: role of neutrophils and thromboxane A2. J. Appl. Physiol. 1994, 77:2817-2826.
6. Chetta A., Foresi A., Marangio E., Olivieri D. Psychological implications of respiratory health and disease. Respiration 2005, 72:210-215.
7. Cromwell O., Hamid Q., Corrigan C.J., Barkans J., Meng Q., Collins P.D., Kay A.B. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony stimulating factor by bronchial epithelial cells and enhancement by IL-1 and tumour necrosis factor-α. Immunology 1992, 77:330-337.
8. Decramer M. Pulmonary rehabilitation 2007: from bench to practice and back. Clin. Invest. Med. 2008, 31:312-318.
9. Di Nuovo S., Rispoli L., Genta E. Misurare lo stress: il test MSP e altri strumenti per una valutazione integrata 2000, F. Angeli, Rome, (in Italian).
10. Elenkov I.J., Iezzoni D.G., Daly A., Harris A.G., Chrousos G.P. Cytokine disregulation, inflammation and well-being. Neuroimmunomodulation 2005, 12:255-269.
11. Glaser R. Stress-associated immune dysregulation and its importance for human health: a personal history of psychoneuroimmunology. Brain Behav. Immun. 2005, 19:3-11.
12. Goebel M.U., Mills P.J., Irwin M.R., Ziegler M.G. Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways. Psychosom. Med. 2000, 62:591-598.
13. Gronke L., Beeh K.M., Cameron R., Kornmann O., Beier J., Shaw M., Holtz O., Buhl R., Magnussen H., Jorres R.A. effect of the oral leukotriene B4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary disease. Pulm. Pharmacol. Ther. 2008, 21:409-417.
14. Hiemstra P.S., Van Wetering S., Stolk J. Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: effects on pulmonary epithelium. Eur. Respir. J. 1998, 12:1200-1208.
15. Hicks A., Monkarsh S.P., Hoffman A.F., Goodnow R. Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developments. Expert Opin. Invest. Drugs 2007, 16:909-1920.
16. Ippoliti F., De Santis W., Volterrani A., Canitano N., Frattolillo D., Lucarelli S., Frediani S., Frediani T. Psychological stress affects response to sublingual immunotherapy in asthmatic children allergic to house dust mite. Pediatr. Allergy Immunol. 2006, 17:337-345.
17. Gruffydd-Jones K., Langley-Johnson C., Dyer C., Badlan K., Ward S. What are the needs of patients following discharge from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD)?. Prim. Care Respir. J. 2007, 16:363-368.
18. Itoh A., Nishihira J., Makita H., Miyamoto K., Yamaguchi E., Nishimura M. Effects of IL-1β, TNF-α, and macrophage migration inhibitory factor on prostacyclin synthesis in rat pulmonary artery smooth muscle cells. Respirology 2003, 8:467-472.
19. Joppa P., Petrasova D., Stancak B., Tkacova R. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest 2006, 130:326-333.
20. Laurin C., Lavoie K.L., Bacon S.L., Dupuis G., Lacoste G., Cartier A., Labrecque M. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest 2007, 132:148-155.
21. Lemyre L., Tessier R. Measuring psychological stress. Concept, model, and measurement instrument in primary care research. Can. Fam. Physician 2003, 49:1159-1160. 1166-1168.
22. Liu L.Y., Coe C.L., Swenson C.A., Kelly E.A., Kita H., Busse W.W. School examinations enhance airway inflammation to antigen challenge. Am. J. Respir. Crit. Care. Med. 2002, 165:1062-1067.
23. Matsuzaki T., Amakawa K., Yamaguchi K., Ishizaka A., Terashima T., Matsumaru A., Morishita T. Effects of diesel exhaust particles on human neutrophil activation. Exp. Lung Res. 2006, 32:427-439.
24. McEwen B.S. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur. J. Pharmacol. 2008, 583:174-185.
25. McMillan R.M. Leukotrienes in respiratory disease. Paediatr. Respir. Rev. 2001, 2:238-244.
26. Pembroke T.P., Rasul F., Hart C.L., Davey Smith G., Stanfeld S.A. Psychological distress and chronic obstructive pulmonary disease in the Renfrew and Paisley (MIDSPAN) study. J. Epidemiol. Commun. Health 2006, 60:789-792.
27. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
28. Riccioni G., Di Ilio C., Conti P., Theoharides T.C., D'Orazio N. Advances on therapy with antileukotriene drugs. Ann. Clin. Lab. Sci. 2004, 34:379-387.
29. Rubinstein I., Kumara B., Schrieverc C. Long-term montelukast therapy in moderate to severe COPD-a preliminary observation. Respir. Med. 2004, 98:134-138.
30. Sandberg S., Jarvenpaa S., Penttinen A., Paton J.Y., McCann D.C. Asthma exacerbations in children immediately following stressful life events: a Cox's hierarchical regression. Thorax 2004, 59:1046-1051.
31. Sapey E., Bayley D., Amhad A., Newbold P., Snell N., Stockley R.A. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax 2008, 63:493-499.
32. Schmitt-Grehe S., Zielen S. Leukotriene receptor antagonists in children with cystic fibrosis lung disease: anti-inflammatory and clinical effects. Paediatr. Drugs 2005, 7:353-363.
33. Shackell B.S., Jones R.C., Harding G., Pearse S., Campbell J. 'Am I going to see the next morning?' A qualitative study of patients perspectives of sleep in COPD. Prim. Care Respir. J. 2007, 16:378-383.
34. Singer H.K., Ruchinskas R.A., Riley K.C., Broshek D.K., Barth J.T. The psychological impact of end-stage lung disease. Chest 2001, 120:1246-1252.
35. Stevens T., Janssen P.L., Tucker A. Acute and long-term TNF-α administration increases pulmonary vascular reactivity in isolated rat lungs. J. Appl. Physiol. 1992, 73:708-712.
36. White A.J., Gompertz S., Stockley R.A. Chronic obstructive pulmonary disease. 6. The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax 2003, 58:73-80.
37. Wright R.J., Cohen R.T., Cohen S. The impact of stress on the development and expression of atopy. Curr. Opin. Allergy Clin. Immunol. 2005, 5:23-29.
38. Xu W., Collet J.P., Shapiro S., Lin Y., Yang T., Platt R.W., Wang C., Bourbeau J. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am. J. Respir. Crit. Care Med. 2008, 178:913-920.